// App-Quantinova.ai

3861 : A Novel Platform For The Identification Of Stromal-Derived Factors That Enhance Acute Lymphoblastic Leukemia Cell Survival In The Context Of Maintenance Chemotherapy

Researchers

Presenter

  • Lauren B Patrick

Principal Investigators

  • Olena Tkachenko

  • Urmila Sivagnanalingam

  • Craig A. Mullen

Medical Centers

  • University of Rochester Medcal Center, Rochester, NY

  • University of Rochester School of Medicine and Dentistry, Rochester, NY

  • Pediatrics (Neonatology), University of Rochester Medical Center, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Telomerase reverse transcriptase

Drug/Treatment

  • 6-mercaptopurine

  • Methotrexate

  • CXCL12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved